Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 17F. Hoffmann-La Roche

02 3Genentech

03 8Roche Diagnostics GmbH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab; Trastuzumab

Brand Name : Phesgo

Dosage Form : Injectable Solution

Dosage Strength : 1200mg;600mg

Packaging :

Approval Date : 21/12/2020

Application Number : 20200111000010

Regulatory Info : Approved

Registration Country : Sweden

blank

02

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab

Brand Name : Perjette

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 420mg

Packaging :

Approval Date : 04/03/2013

Application Number : 20111229000055

Regulatory Info : Approved

Registration Country : Sweden

blank

03

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab

Brand Name : Perjeta

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 420mg/14ml

Packaging :

Approval Date : 13/08/2012

Application Number : 62510

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumabum; Trastuzumabum

Brand Name : Phesgo mg

Dosage Form : Solution For Injection

Dosage Strength : 600mg/10ml;600mg/10ml

Packaging :

Approval Date : 08/04/2021

Application Number : 67828

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumabum; Trastuzumabum

Brand Name : Phesgo mg

Dosage Form : Solution For Injection

Dosage Strength : 1200mg/15ml;600mg/15ml

Packaging :

Approval Date : 08/04/2021

Application Number : 67828

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab; Trastuzumab

Brand Name : Phesgo

Dosage Form : Injectable Solution

Dosage Strength : 600mg/ml;600mg/ml

Packaging :

Approval Date : 21/12/2020

Application Number : 20200111000027

Regulatory Info : Approved

Registration Country : Sweden

blank

07

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

PERTUZUMAB

Brand Name : PERJETA

Dosage Form : SOLUTION

Dosage Strength : 420MG/14ML

Packaging : 14ML

Approval Date :

Application Number : 2405016

Regulatory Info : Prescription

Registration Country : Canada

blank

08

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

PERTUZUMAB

Brand Name : PERJETA-HERCEPTIN

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 420MG/14ML

Packaging : 14ML & 20ML

Approval Date :

Application Number : 2405024

Regulatory Info : Schedule D

Registration Country : Canada

blank

09

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

PERTUZUMAB

Brand Name : PHESGO

Dosage Form : SOLUTION

Dosage Strength : 80MG/ML

Packaging :

Approval Date :

Application Number : 2512912

Regulatory Info : Schedule D

Registration Country : Canada

blank

10

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

PERTUZUMAB

Brand Name : PERJETA

Dosage Form : VIAL; SINGLE-USE

Dosage Strength : 420MG/14ML

Packaging :

Approval Date :

Application Number : 125409

Regulatory Info :

Registration Country : USA

blank

11

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 1,200MG;600MG;30,000UNITS

Packaging :

Approval Date :

Application Number : 761170

Regulatory Info :

Registration Country : USA

blank

12

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Brand Name : PHESGO

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 600MG;600MG;20,000UNITS

Packaging :

Approval Date :

Application Number : 761170

Regulatory Info :

Registration Country : USA

blank

13

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Trastuzumab; Pertuzumab

Brand Name : Phesgo

Dosage Form : Injection Solution

Dosage Strength : 600MG; 600 MG

Packaging :

Approval Date : 2021-02-09

Application Number : 1201497002

Regulatory Info : Authorized

Registration Country : Spain

blank

14

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Trastuzumab; Pertuzumab

Brand Name : Phesgo

Dosage Form : Injection Solution

Dosage Strength : 1200MG; 600 MG

Packaging :

Approval Date : 2021-11-02

Application Number : 1201497001IP

Regulatory Info : Authorized

Registration Country : Spain

blank

15

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Trastuzumab; Pertuzumab

Brand Name : Phesgo

Dosage Form : Injection Solution

Dosage Strength : 600MG; 600 MG

Packaging :

Approval Date : 2021-11-02

Application Number : 1201497002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

16

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Trastuzumab; Pertuzumab

Brand Name : Phesgo

Dosage Form : Injection Solution

Dosage Strength : 1200MG; 600 MG

Packaging :

Approval Date : 2021-02-09

Application Number : 1201497001

Regulatory Info : Authorized

Registration Country : Spain

blank

17

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab

Brand Name : Perjeta

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 420MG

Packaging :

Approval Date : 2013-03-12

Application Number : 113813001

Regulatory Info : Authorized

Registration Country : Spain

blank

18

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab

Brand Name : Perjeta

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 420MG

Packaging :

Approval Date : 2024-05-09

Application Number : 113813001IP2

Regulatory Info : Authorized

Registration Country : Spain

blank

19

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab

Brand Name : Perjeta

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 420MG

Packaging :

Approval Date : 2019-11-06

Application Number : 113813001IP

Regulatory Info : Authorized

Registration Country : Spain

blank

20

CPhI India
Not Confirmed
arrow
arrow
CPhI India
Not Confirmed

Pertuzumab

Brand Name : Perjeta

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 420MG

Packaging :

Approval Date : 2021-04-06

Application Number : 113813001IP1

Regulatory Info : Authorized

Registration Country : Spain

blank